TY - JOUR
T1 - The Uppsala APP deletion causes early onset autosomal dominant Alzheimer's disease by altering APP processing and increasing amyloid β fibril formation
AU - De la Vega, María Pagnon
AU - Giedraitis, Vilmantas
AU - Michno, Wojciech
AU - Kilander, Lena
AU - Güner, Gökhan
AU - Zielinski, Mara
AU - Löwenmark, Malin
AU - Brundin, Rose Marie
AU - Danfors, Torsten
AU - Söderberg, Linda
AU - Alafuzoff, Irina
AU - Nilsson, Lars N.G.
AU - Erlandsson, Anna
AU - Willbold, Dieter
AU - Müller, Stephan A.
AU - Schröder, Gunnar F.
AU - Hanrieder, Jörg
AU - Lichtenthaler, Stefan F.
AU - Lannfelt, Lars
AU - Sehlin, Dag
AU - Ingelsson, Martin
N1 - Publisher Copyright:
© 2021 American Association for the Advancement of Science. All rights reserved.
PY - 2021/8/11
Y1 - 2021/8/11
N2 - Point mutations in the amyloid precursor protein gene (APP) cause familial Alzheimer's disease (AD) by increasing generation or altering conformation of amyloid β (Aβ). Here, we describe the Uppsala APP mutation (Δ690-695), the first reported deletion causing autosomal dominant AD. Affected individuals have an age at symptom onset in their early forties and suffer from a rapidly progressing disease course. Symptoms and biomarkers are typical of AD, with the exception of normal cerebrospinal fluid (CSF) Aβ42 and only slightly pathological amyloid-positron emission tomography signals. Mass spectrometry and Western blot analyses of patient CSF and media from experimental cell cultures indicate that the Uppsala APP mutation alters APP processing by increasing β-secretase cleavage and affecting α-secretase cleavage. Furthermore, in vitro aggregation studies and analyses of patient brain tissue samples indicate that the longer form of mutated Aβ, AβUpp1-42Δ19-24, accelerates the formation of fibrils with unique polymorphs and their deposition into amyloid plaques in the affected brain.
AB - Point mutations in the amyloid precursor protein gene (APP) cause familial Alzheimer's disease (AD) by increasing generation or altering conformation of amyloid β (Aβ). Here, we describe the Uppsala APP mutation (Δ690-695), the first reported deletion causing autosomal dominant AD. Affected individuals have an age at symptom onset in their early forties and suffer from a rapidly progressing disease course. Symptoms and biomarkers are typical of AD, with the exception of normal cerebrospinal fluid (CSF) Aβ42 and only slightly pathological amyloid-positron emission tomography signals. Mass spectrometry and Western blot analyses of patient CSF and media from experimental cell cultures indicate that the Uppsala APP mutation alters APP processing by increasing β-secretase cleavage and affecting α-secretase cleavage. Furthermore, in vitro aggregation studies and analyses of patient brain tissue samples indicate that the longer form of mutated Aβ, AβUpp1-42Δ19-24, accelerates the formation of fibrils with unique polymorphs and their deposition into amyloid plaques in the affected brain.
UR - http://www.scopus.com/inward/record.url?scp=85113353466&partnerID=8YFLogxK
U2 - 10.1126/scitranslmed.abc6184
DO - 10.1126/scitranslmed.abc6184
M3 - Article
C2 - 34380771
AN - SCOPUS:85113353466
SN - 1946-6234
VL - 13
JO - Science Translational Medicine
JF - Science Translational Medicine
IS - 606
M1 - eabc6184
ER -